Contrast-enhanced Ultrasound Market Size & Share, by Type (Microbubble Contrast Agents, Phase-Change Contrast Agents); Technology (Targeted, Non-targeted); End User (Hospitals, Diagnostic Imaging Centers, Research and Academic Institutions) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5642
  • Published Date: May 02, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Contrast-enhanced Ultrasound Market size is anticipated to reach USD 24 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of contrast-enhanced ultrasound was over USD 10 billion. The industry growth is driven by an increase in R&D activities, collaboration, product approvals, and launches.

In other words, ultrasound experts called on the healthcare community in October 2021 to work towards wider use of ultrasound contrast agents so as to offer patients better access to less expensive, safer, and more accurate medical imaging. This is also expected to create opportunities for the CEUS, which is expected to contribute to the growth of the market.

Moreover, the real-time imaging capabilities of contrast-enhanced ultrasound add a layer of diagnostic precision, allowing clinicians to observe dynamic processes within the body, such as blood flow and tissue perfusion, in real-time. This real-time feedback not only aids in accurate diagnosis but also enhances procedural guidance, making it an attractive choice for interventions and therapeutic monitoring.

Contrast Enhanced Ultrasound Market
Get more information on this report: Request Free Sample PDF

Contrast-enhanced Ultrasound Sector: Growth Drivers and Challenges

Growth Drivers

  • Advancements in ultrasound technology - One of the most important factors escalating the contrast-enhanced ultrasound market expansion is the constant advancement taking place in ultrasound technology. In addition, breakthroughs in transducer technology, image processing algorithms, and the development of next-generation contrast agents have contributed to improving the CEUS' diagnosis capabilities.

    Technological advances in ultrasound, such as improved transducer technology and image processing algorithms, have contributed to a 25% increase in the diagnostic accuracy of ultrasound images over the last 10 years, according to an article.
  • Growing applications in oncology - The growing application of contrast-enhanced ultrasound in the oncology sector is foreseen to escalate the contrast-enhanced ultrasound market demand further. Contrast-enhanced ultrasound has been beneficial for identifying various types of solid tumors that have played a vital role in the diagnosis of cancer and further treatment procedures.

    Therefore, for the appropriate identification of the stage of cancer and the development of required treatment, real-time tumor recognition is important in the field of oncology.
  • Surge in the demand for non-invasive imaging techniques - The growth of this market can also be propelled by the expanding demand for non-invasive imaging techniques taking place regularly. CEUS has become a significant part of diagnostic imaging as the demand for procedures that mitigate patient discomfort and reduce exposure to ionizing radiation has become notable.

    Furthermore, the growing need for non-invasive imaging techniques can be accounted on the back of the increasing number of benefits it has to offer in comparison with other traditional techniques such as CT scan or MRI.


  • Limited reimbursement policies - Reimbursement for CEUS procedures varies across regions and healthcare systems, often leading to uncertainty and financial constraints for both healthcare providers and patients.

    Despite the clinical benefits and growing adoption of CEUS, reimbursement policies for contrast-enhanced ultrasound examinations may not be well-established or adequately aligned with the costs associated with the technology. This discrepancy can deter healthcare facilities from investing in CEUS equipment and hinder patient access to this advanced imaging modality.
  • Limited Awareness is predicted to hamper the growth of the market in the forecast period.
  • High cost and availability issues associated with contrasting agents.

Contrast-enhanced Ultrasound Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

USD 10 Billion

Forecast Year Market Size (2036)

USD 24 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Contrast-enhanced Ultrasound Segmentation

Type (Microbubble Contrast Agents, Phase-Change Contrast Agents)

In terms of type, the microbubble contrast agents segment is estimated to gain the largest contrast-enhanced ultrasound market share of 60% in the year 2036. The microbubble contrast agent segment growth can be accounted for on the back of increasing cases of liver-related diseases including cirrhosis and hepatocellular carcinoma.

Liver diseases often require precise imaging for accurate diagnosis and monitoring of lesions, and microbubble contrast agents enhance the visibility of vascular structures and lesions during ultrasound imaging. Around a 25% rise has been recorded annually in the incidence of hepatocellular carcinoma globally in the last decade, reported as per a study.

This rapid growth in liver diseases underscores the critical need for advanced imaging techniques, such as contrast-enhanced ultrasound with microbubble contrast agents, for effective diagnosis and management. Continuous advancements in ultrasound technology, including improvements in transducer design and image processing algorithms, are driving the growth of the microbubble contrast agents segment.

End Users (Hospitals, Diagnostic Imaging Centers, Research and Academic Institutions)

Based on end users, the hospital segment is expected to garner the highest CAGR of 50% during the projected timeframe. Hospitals serve as primary centers for diagnosing and managing liver diseases, and the demand for CEUS in this segment is driven by the need for accurate and non-invasive imaging to assess liver lesions.

The hospital segment growth is assessed to rise due to increasing cardiovascular disease cases recorded globally. Hospitals play a central role in cardiovascular care, and the utilization of CEUS for cardiac imaging contributes to the comprehensive assessment of patients with conditions such as myocardial infarction, heart failure, and valvular disorders.

Our in-depth analysis of the global market includes the following segments:



  • Microbubble Contrast Agents
  • Phase-Change Contrast Agents

            End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Research and Academic Institutions


  • Targeted
  • Non-targeted

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Contrast-enhanced Ultrasound Industry - Regional Synopsis

North American Market Statistics

The North America region contrast-enhanced ultrasound market is set to observe the highest growth of 33% during the review period. The market in this region is expected to escalate on account of growing technological development in medical imaging, as CEUS, with its application in cardiovascular imaging, plays a crucial role in assessing myocardial perfusion and detecting cardiac abnormalities.

The region's commitment to innovation in healthcare technology drives the integration of advanced imaging modalities into clinical practice. Also, kidney-related disorders like chronic kidney disease and renal vascular abnormalities are becoming common cases in this region.  

APAC Market Analysis

The contrast-enhanced ultrasound market in the Asia Pacific region is poised to witness a notable revenue share of 27% by the end of 2036. The need for accurate diagnostic instruments like CEUS is growing as it's a major contributor to morbidity and death in the area.

 According to a survey, the frequency of chronic hepatitis B and C infections has increased by 30% across the Asia Pacific area over the last ten years, underscoring the growing prevalence of liver illnesses. The population of the Asia Pacific area is aging quickly, causing a shift in demographics, as a result heart disease is becoming more common as a result of this demographic shift.

Research Nester
Contrast Enhanced Ultrasound Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Contrast-Enhanced Ultrasound Landscape

    • General Electric Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Siemens Healthineers
    • Philips Healthcare
    • Lantheus Holdings, Inc.
    • Bracco Diagnostic
    • GE HealthCare
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

In the News

  • Siemens Healthineer's transformative possession established it as a leader in holistic cancer care, combining Varian's radiation therapy expertise with its existing imaging and therapy portfolio
  • GE HealthCare has received a USD 44 million grant from the B2B Foundation to develop AI-powered ultrasound technology. The funding will support the development of cutting-edge auto-evaluation applications and ultrasound imaging tools that leverage artificial intelligence. This new technology is going to emphasize respiratory, fetal, and maternal health. The project will be headed by Caption Health which was recently taken by GE Healthcare and now is made to work on multiple ultrasound devices and probes comprising affordable and compact devices.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5642
  • Published Date: May 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of contrast-enhanced ultrasound was over USD 10 billion.

The market size for contrast-enhanced ultrasound is projected to cross USD 24 billion by the end of 2036 expanding at a CAGR of 8% during the forecast period i.e., between 2024-2036.

The major players in the market are Lantheus Holdings, Inc., Hitachi, Ltd., Toshiba Corporation, FUJIFILM Holdings Corporation, Mindray Medical International Limited, Samsung Medison Co., Ltd., and others.

In terms of end-users, the hospital segment is set to account for the largest market share of 50% during 2024-2036.

The North America contrast-enhanced ultrasound sector is poised to hold the highest share of 33% by 2036.
Contrast Enhanced Ultrasound Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying